eccogene glp 1 Announces Positive Topline Results from Phase 1b Trial of Elecoglipron (AZD5004/ECC5004), an Oral GLP-1 Receptor Agonist, in Adult Participants Living with Obesity/Overweight, with or without Type 2 Diabetes in China Elecoglipron Shows Positive Results in

This study employed a multi-omics approach, integrating transcriptomic, metabolomic, and gut microbiota analyses, to identify key pathways and interactions underlying these metabolic disturbances (Song X

Genetic Factors That Influence Your Response to Metabolic Changes Your genetic makeup influences how efficiently you generate and regulate body heat during weight loss, with key variants in the FTO (fat mass and obesity-associated) gene affecting metabolic rate and thermogenesis

The appeal of a patch lies in its convenience, reduced pain, and ease of use, making it an attractive option for individuals who dislike needles

Within this database, they identified 638,501 individuals with a prior occurrence of acute pancreatitis

November 2023 : Eli Lilly received US FDA approval for ZEPBOUND, an obesity treatment that activates GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors

The persistence of hyperglycemia in diabetes triggers a sequence of local metabolic, vascular, and neurochemical modifications, which ultimately culminate in vascular disease and microangiopathy [25]